The pharmaceutical industry invested €175 million in basic research, marking an 11% growth from 2021. This allocation represents one in eight euros for biomedical R&D, emphasizing...
The Trak Health Solutions application seeks to offer health professionals and clients an advanced platform to manage rehabilitation treatments. As a novelty, this service integrates telecare...
Seagen expects to generate $2.2 billion (€2.063 billion) in revenue in 2023 , which will represent a 12% year-on-year increase for the biotech company. Pfizer expects...
In the new operating room, percutaneous and open vascular techniques will be carried out, that is, combining ultrasound-guided, X-ray-guided procedures and conventional open techniques in the...
Werfen is chaired by Marc Rubiralta and in 2022 it achieved a turnover of €1.84 billion. In the largest operation in its history, the group closed...
Paris-based Aqemia will receive upfront and milestone payments under the deal that will be used to deepen R&D. In addition, it plans to double its workforce...
With a history of 170 years, Aspen is a multinational pharmaceutical company with a presence in both emerging and developed markets. It has approximately 9,100 employees,...
Embedded within the Strategic Plan for Economic Recovery for Vanguard Health, this initiative is funded through the Recovery, Resilience, and Transformation Mechanism. It will benefit 43...
Roche is set to acquire Carmot Therapeutics, along with three clinical-stage assets for treating obesity and diabetes, for a maximum of €2.85 billion. The agreement involves...
ALA Diagnostics secured €1.1 million in a financing round in June, supporting its activities in the general laboratory, including Elisa tests. The company also focuses on...